Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03663673 · ClinicalTrials.gov registry record · Phase 1
Effect of Different Skin Creams on TEWL
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT03663673: Completed Phase 1 study, sponsored by Stanford University.
NCT03663673 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03663673, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
Prospective, single center, clinical pilot study to test the hypothesis that lipid rich EpiCeram® is superior in improving skin barrier function compared to Aveeno Daily Moisturising Sheer Hydration Lotion®.
Interventions
- DRUG EpiCeram
- DRUG Aveeno Daily Moisturising Sheer Hydration Lotion®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2019-07-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03663673
The ClinicalTrials.gov registry entry for NCT03663673 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EpiCeram is the first listed.
NCT03663673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03663673 about?
NCT03663673 is a clinical study titled "Effect of Different Skin Creams on TEWL". Prospective, single center, clinical pilot study to test the hypothesis that lipid rich EpiCeram® is superior in improving skin barrier function compared to Aveeno Daily Moisturising Sheer Hydration Lotion®.
What is the current status of trial NCT03663673?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2018-09-01. Estimated completion is 2019-07-18.
What interventions are being tested in trial NCT03663673?
The interventions under investigation include: EpiCeram (DRUG), Aveeno Daily Moisturising Sheer Hydration Lotion® (DRUG).
Who is sponsoring clinical trial NCT03663673?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.